Is CTCX or JNJ a better dividend investment in 2026?

CTCX currently yields 1013.68% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CTCX offers higher current income.

What is the dividend yield difference between CTCX and JNJ?

CTCX has a forward dividend yield of 1013.68% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1010.32 percentage points.

Home › Compare › CTCX vs JNJ

CTCX vs JNJ: Dividend Comparison 2026

CTCX yields 1013.68% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CTCX wins by $21217097.11M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CTCX

● Live price

1013.68%

Share price

$0.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21217097.13M

Annual income

$17,768,877,895,719.51

Full CTCX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CTCX vs JNJ

📍 CTCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CTCX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CTCX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CTCX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCX

Annual income on $10K today (after 15% tax)

$86,163.20/yr

After 10yr DRIP, annual income (after tax)

$15,103,546,211,361.58/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, CTCX beats the other by $15,103,546,210,657.97/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCX + JNJ for your $10,000?

CTCX: 50%JNJ: 50%

100% JNJ50/50100% CTCX

Portfolio after 10yr

$10608548.57M

Annual income

$8,884,438,948,273.64/yr

Blended yield

83.75%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CTCX

No analyst data

Altman Z

-56.1

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCX buys

JNJ buys

No recent congressional trades found for CTCX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCTCXJNJ

Forward yield	1013.68% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$21217097.13M ✓	$20.0K
Annual income after 10y	$17,768,877,895,719.51 ✓	$827.78
Total dividends collected	$20954125.95M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CTCX vs JNJ ($10,000, DRIP)

Year	CTCX Portfolio	CTCX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$112,068	$101,368.47	$10,676	$355.77	+$101.4K → CTCX
2	$1,181,615	$1,061,701.90	$11,407	$389.39	+$1.17M → CTCX
3	$11,726,249	$10,461,920.38	$12,198	$426.53	+$11.71M → CTCX
4	$109,578,123	$97,031,037.37	$13,056	$467.62	+$109.57M → CTCX
5	$964,654,833	$847,406,240.94	$13,987	$513.12	+$964.64M → CTCX
6	$8,004,158,004	$6,971,977,332.68	$14,998	$563.56	+$8004.14M → CTCX
7	$62,629,410,485	$54,064,961,420.43	$16,098	$619.52	+$62629.39M → CTCX
8	$462,375,346,702	$395,361,877,482.99	$17,295	$681.69	+$462375.33M → CTCX
9	$3,222,634,793,872	$2,727,893,172,901.40	$18,599	$750.82	+$3222634.78M → CTCX
10	$21,217,097,125,163	$17,768,877,895,719.51	$20,022	$827.78	+$21217097.11M → CTCX

CTCX vs JNJ: Complete Analysis 2026

CTCX — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CTCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCX vs SCHD CTCX vs JEPI CTCX vs O CTCX vs KO CTCX vs MAIN CTCX vs ABBV CTCX vs MRK CTCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.